Document Detail


Cholesterol crystal embolism: Diagnostic and treatment.
MedLine Citation:
PMID:  17024171     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
D Kryvoshey; M Kammerl; U Hoffmann; A Obed; B K Krämer
Publication Detail:
Type:  Case Reports; Comment; Letter    
Journal Detail:
Title:  Kidney international     Volume:  70     ISSN:  0085-2538     ISO Abbreviation:  Kidney Int.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-10-06     Completed Date:  2006-11-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0323470     Medline TA:  Kidney Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1525; author reply 1525     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Artery Disease / drug therapy
Embolism, Cholesterol / complications,  diagnosis*,  prevention & control,  therapy*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Kidney Failure, Chronic / etiology,  therapy
Kidney Transplantation*
Male
Middle Aged
Renal Dialysis
Chemical
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors
Comments/Corrections
Comment On:
Kidney Int. 2006 Apr;69(8):1308-12   [PMID:  16614719 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is there a need to optimize glycemic control in hemodialyzed diabetic patients?
Next Document:  Oxidative modification of M-type K(+) channels as a mechanism of cytoprotective neuronal silencing.